Anti-Apoptotic Effects of Lentiviral Vector Transduction Promote Increased Rituximab Tolerance in Cancerous B-Cells.
Diffuse large B-cell lymphoma (DLBCL) is characterized by great genetic and clinical heterogeneity which complicates prognostic prediction and influences treatment efficacy. The most common regimen, R-CHOP, consists of a combination of anthracycline- and immuno-based drugs including Rituximab. It re...
Main Authors: | Benyamin Ranjbar, Louise Bechmann Krogh, Maria Bach Laursen, Maria Nascimento Primo, Sara Correia Marques, Karen Dybkær, Jacob Giehm Mikkelsen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4821607?pdf=render |
Similar Items
-
Targeted genome editing by lentiviral protein transduction of zinc-finger and TAL-effector nucleases
by: Yujia Cai, et al.
Published: (2014-04-01) -
Minimal impact of ZAP on lentiviral vector production and transduction efficiency
by: Helin Sertkaya, et al.
Published: (2021-12-01) -
Toward Tightly Tuned Gene Expression Following Lentiviral Vector Transduction
by: Audrey Page, et al.
Published: (2020-12-01) -
Lentiviral vector transduction of spermatozoa as a tool for the study of early development
by: Anil Chandrashekran, et al.
Published: (2014-01-01) -
Engineering fusogenic molecules to achieve targeted transduction of enveloped lentiviral vectors
by: Wang Pin, et al.
Published: (2009-06-01)